The iconic rise of Viagra has firmly established as a example of pharmaceutical success, but its position within the broader sector now triggers questions about potential returns . Alternative versions are eroding patent protection , causing concerns that betting on companies significantly dependent to Viagra's once-dominant position could be a spe